Since ZNF298 is located on chromosome 21q22.3 and duplication of this segment is strongly associated with the development of Down syndrome (150, 151), dosage abnormality in ZNF298 appears to contribute to the development of some manifestations of this disease (152). This evidence concerns the gene PRDM15 and Down syndrome.